Literature DB >> 1928065

C1q nephropathy: a pediatric clinicopathologic study.

S S Iskandar1, M C Browning, W B Lorentz.   

Abstract

We report on 15 children with proteinuria, at the nephrotic level in the majority of cases, who had no histologic glomerular alterations (eight cases), or focal and segmental glomerular scarring with (three cases) or without (four cases) mesangial proliferation. In all cases, immunofluorescence (IF) microscopy showed prominent mesangial C1q deposits with variable amounts of immunoglobulins. Ultrastructurally, most had conspicuous mesangial electron-dense deposits. Cases with no glomerular histologic alterations were histologically indistinguishable from minimal change disease (MCD), yet they uniformly had an unsatisfactory response to oral prednisone. Thus, the presence of immune deposits with a prominent C1q contribution identifies a group of cases that respond poorly to steroids and that, if light microscopy is considered in isolation, might otherwise be designated MCD.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1928065     DOI: 10.1016/s0272-6386(12)80114-4

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  31 in total

1.  Change in C1q deposition in C1q nephropathy.

Authors:  Kazunari Kaneko; Masafumi Hasui; Ken Hatae; Hidenori So; Ritsuko Katafuchi
Journal:  Pediatr Nephrol       Date:  2009-03-14       Impact factor: 3.714

Review 2.  C1q nephropathy in the pediatric population: pathology and pathogenesis.

Authors:  Scott E Wenderfer; Rita D Swinford; Michael C Braun
Journal:  Pediatr Nephrol       Date:  2010-02-24       Impact factor: 3.714

3.  C1q nephropathy with asymptomatic urine abnormalities.

Authors:  Masashi Nishida; Hidekazu Kawakatsu; Yasuko Okumura; Kenji Hamaoka
Journal:  Pediatr Nephrol       Date:  2005-08-16       Impact factor: 3.714

4.  C1q nephropathy in children: clinical characteristics and outcome.

Authors:  Vindya N Gunasekara; Neil J Sebire; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2013-12-11       Impact factor: 3.714

Review 5.  Bartter syndrome complicated by immune complex nephropathy. Case report and literature review.

Authors:  Yahya Sardani; Kenan Qin; Mark Haas; Andrew J Aronson; Robert L Rosenfield
Journal:  Pediatr Nephrol       Date:  2003-06-26       Impact factor: 3.714

6.  C1q nephropathy in two young sisters.

Authors:  Jameela A Kari; Sawsan M Jalalah
Journal:  Pediatr Nephrol       Date:  2007-10-21       Impact factor: 3.714

7.  Rituximab treatment of collapsing C1q glomerulopathy: clinical and histopathological evolution.

Authors:  Martin Bitzan; Jodie D Ouahed; Preetha Krishnamoorthy; Chantal Bernard
Journal:  Pediatr Nephrol       Date:  2008-03-20       Impact factor: 3.714

8.  A case of congenital nephrotic syndrome associated with positive C1q immunofluorescence.

Authors:  M Kuwano; Y Ito; Y Amamoto; K Aida
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

9.  C1q nephropathy and minimal change nephrotic syndrome.

Authors:  Craig S Wong; Christopher A Fink; Jane Baechle; Alexis A Harris; Amy O Staples; John R Brandt
Journal:  Pediatr Nephrol       Date:  2008-12-11       Impact factor: 3.714

10.  A single-center study of C1q nephropathy in children.

Authors:  Isabel Roberti; Noosha Baqi; Shefali Vyas; Dae Un Kim
Journal:  Pediatr Nephrol       Date:  2008-08-08       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.